XML 25 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Share Holders’ Equity - USD ($)
Total
Ordinary Shares No Par Value
Additional Paid-in Capital
Accumulated Other Comprehensive Income/(loss)
Statutory Reserve
Retained Earnings
Non-Controlling Interest
Balance at Dec. 31, 2020 $ 50,661,462 $ 13,707,398 $ (62,925) $ 4,517,117 $ 26,728,332 $ 5,771,540
Balance (in Shares) at Dec. 31, 2020   10,225,142          
Restricted stock grant 66,200 66,200
Restricted stock grant (in Shares)   66,200          
Sale of stock and warrants 8,209,897 8,209,897
Sale of stock and warrants (in Shares)   1,038,188          
Debt of the cancelled company 1,775,869 1,775,869  
Proceeds from NCI's Investment 5,386,307 5,386,307
Net income 7,268,221 6,265,578 1,002,643
Transfer to statutory reserve (674,786) 674,786
Foreign currency translation adjustment 1,476,710 1,077,324 399,386
Balance at Dec. 31, 2021 74,844,666 23,759,364 1,014,399 3,842,331 33,668,696 12,559,876
Balance (in Shares) at Dec. 31, 2021   11,329,530          
Sale of stock and warrants 9,196,563 9,196,563
Sale of stock and warrants (in Shares)   1,648,974          
Proceeds from NCI's Investment            
Net income 6,616,695 3,559,565 3,057,130
Foreign currency translation adjustment (5,740,161) (3,845,818) (1,894,343)
Balance at Dec. 31, 2022 $ 84,917,763 $ 32,955,927 $ (2,831,419) $ 3,842,331 $ 37,228,261 $ 13,722,663
Balance (in Shares) at Dec. 31, 2022   12,978,504